Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation

<b>Background</b>: Prior studies suggest that patients’ body composition changes following transjugular intrahepatic portosystemic shunt (TIPS) implantation, potentially influencing complications and survival. <b>Method</b>: A prototype artificial intelligence (AI)-based, aut...

Full description

Saved in:
Bibliographic Details
Main Authors: Laura Büttner, Annette Aigner, Regina Stegherr, Simon Iseke, Martin Jonczyk, Willie Magnus Lüdemann, Timo Alexander Auer, Federico Collettini, Dirk Schnapauff, Maximilian de Bucourt, Bernhard Gebauer, Dominik Geisel, Georg Böning
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/15/11/1440
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849722291543343104
author Laura Büttner
Annette Aigner
Regina Stegherr
Simon Iseke
Martin Jonczyk
Willie Magnus Lüdemann
Timo Alexander Auer
Federico Collettini
Dirk Schnapauff
Maximilian de Bucourt
Bernhard Gebauer
Dominik Geisel
Georg Böning
author_facet Laura Büttner
Annette Aigner
Regina Stegherr
Simon Iseke
Martin Jonczyk
Willie Magnus Lüdemann
Timo Alexander Auer
Federico Collettini
Dirk Schnapauff
Maximilian de Bucourt
Bernhard Gebauer
Dominik Geisel
Georg Böning
author_sort Laura Büttner
collection DOAJ
description <b>Background</b>: Prior studies suggest that patients’ body composition changes following transjugular intrahepatic portosystemic shunt (TIPS) implantation, potentially influencing complications and survival. <b>Method</b>: A prototype artificial intelligence (AI)-based, automated computed tomography (CT) body composition analysis tool was used to assess body composition imaging parameters in pre- and postinterventional scans of TIPS patients: visceral (VAT) and subcutaneous adipose tissue (SAT) areas, psoas muscle area (PMA), and total abdominal muscle area (TAMA). Sarcopenia was defined as a lumbar skeletal muscle index (LSMI) ≤ 38.5 cm<sup>2</sup>/m<sup>2</sup> in women and ≤52.4 cm<sup>2</sup>/m<sup>2</sup> in men. We analyzed longitudinal changes in body composition and investigated the impact of sarcopenia at TIPS implantation on the risk of TIPS thrombosis, hepatic encephalopathy, complications, and death using Cox regression models. <b>Results</b>: No clear trend emerged regarding changes in body composition parameters during postinterventional follow-up. Sarcopenia at TIPS implantation increased the instantaneous risk of postinterventional complications (hazard ratio (HR) 1.67; 95% confidence interval (CI) 0.95–2.93), development of hepatic encephalopathy (HR 1.65; 0.81–3.33), as well as the risk of dying within one year (HR 1.39; 0.66–2.92). <b>Conclusions</b>: CT body composition analysis may help in identifying high-risk patients undergoing TIPS implantation. Sarcopenia was associated with increased mortality and a higher incidence of postinterventional complications, particularly hepatic encephalopathy.
format Article
id doaj-art-42f0b8dbee7b4152b0f8d23c2d5e35c0
institution DOAJ
issn 2075-4418
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj-art-42f0b8dbee7b4152b0f8d23c2d5e35c02025-08-20T03:11:22ZengMDPI AGDiagnostics2075-44182025-06-011511144010.3390/diagnostics15111440Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) ImplantationLaura Büttner0Annette Aigner1Regina Stegherr2Simon Iseke3Martin Jonczyk4Willie Magnus Lüdemann5Timo Alexander Auer6Federico Collettini7Dirk Schnapauff8Maximilian de Bucourt9Bernhard Gebauer10Dominik Geisel11Georg Böning12Department of Radiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Charitéplatz 1, 10117 Berlin, GermanyInstitute of Biometry and Clinical Epidemiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Charitéplatz 1, 10117 Berlin, GermanyInstitute of Biometry and Clinical Epidemiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Charitéplatz 1, 10117 Berlin, GermanyDepartment of Diagnostic and Interventional Radiology, Pediatric Radiology and Neuroradiology, Rostock University Medical Center, 18057 Rostock, GermanyDepartment of Radiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Charitéplatz 1, 10117 Berlin, GermanyDepartment of Radiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Charitéplatz 1, 10117 Berlin, GermanyDepartment of Radiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Charitéplatz 1, 10117 Berlin, GermanyDepartment of Radiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Charitéplatz 1, 10117 Berlin, GermanyDepartment of Radiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Charitéplatz 1, 10117 Berlin, GermanyDepartment of Radiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Charitéplatz 1, 10117 Berlin, GermanyDepartment of Radiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Charitéplatz 1, 10117 Berlin, GermanyDepartment of Radiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Charitéplatz 1, 10117 Berlin, GermanyDepartment of Radiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany<b>Background</b>: Prior studies suggest that patients’ body composition changes following transjugular intrahepatic portosystemic shunt (TIPS) implantation, potentially influencing complications and survival. <b>Method</b>: A prototype artificial intelligence (AI)-based, automated computed tomography (CT) body composition analysis tool was used to assess body composition imaging parameters in pre- and postinterventional scans of TIPS patients: visceral (VAT) and subcutaneous adipose tissue (SAT) areas, psoas muscle area (PMA), and total abdominal muscle area (TAMA). Sarcopenia was defined as a lumbar skeletal muscle index (LSMI) ≤ 38.5 cm<sup>2</sup>/m<sup>2</sup> in women and ≤52.4 cm<sup>2</sup>/m<sup>2</sup> in men. We analyzed longitudinal changes in body composition and investigated the impact of sarcopenia at TIPS implantation on the risk of TIPS thrombosis, hepatic encephalopathy, complications, and death using Cox regression models. <b>Results</b>: No clear trend emerged regarding changes in body composition parameters during postinterventional follow-up. Sarcopenia at TIPS implantation increased the instantaneous risk of postinterventional complications (hazard ratio (HR) 1.67; 95% confidence interval (CI) 0.95–2.93), development of hepatic encephalopathy (HR 1.65; 0.81–3.33), as well as the risk of dying within one year (HR 1.39; 0.66–2.92). <b>Conclusions</b>: CT body composition analysis may help in identifying high-risk patients undergoing TIPS implantation. Sarcopenia was associated with increased mortality and a higher incidence of postinterventional complications, particularly hepatic encephalopathy.https://www.mdpi.com/2075-4418/15/11/1440body compositioncomputed tomographytransjugular intrahepatic portosystemic shuntsarcopenia
spellingShingle Laura Büttner
Annette Aigner
Regina Stegherr
Simon Iseke
Martin Jonczyk
Willie Magnus Lüdemann
Timo Alexander Auer
Federico Collettini
Dirk Schnapauff
Maximilian de Bucourt
Bernhard Gebauer
Dominik Geisel
Georg Böning
Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation
Diagnostics
body composition
computed tomography
transjugular intrahepatic portosystemic shunt
sarcopenia
title Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation
title_full Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation
title_fullStr Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation
title_full_unstemmed Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation
title_short Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation
title_sort sarcopenia as a risk factor in patients undergoing transjugular intrahepatic portosystemic shunt tips implantation
topic body composition
computed tomography
transjugular intrahepatic portosystemic shunt
sarcopenia
url https://www.mdpi.com/2075-4418/15/11/1440
work_keys_str_mv AT laurabuttner sarcopeniaasariskfactorinpatientsundergoingtransjugularintrahepaticportosystemicshunttipsimplantation
AT annetteaigner sarcopeniaasariskfactorinpatientsundergoingtransjugularintrahepaticportosystemicshunttipsimplantation
AT reginastegherr sarcopeniaasariskfactorinpatientsundergoingtransjugularintrahepaticportosystemicshunttipsimplantation
AT simoniseke sarcopeniaasariskfactorinpatientsundergoingtransjugularintrahepaticportosystemicshunttipsimplantation
AT martinjonczyk sarcopeniaasariskfactorinpatientsundergoingtransjugularintrahepaticportosystemicshunttipsimplantation
AT williemagnusludemann sarcopeniaasariskfactorinpatientsundergoingtransjugularintrahepaticportosystemicshunttipsimplantation
AT timoalexanderauer sarcopeniaasariskfactorinpatientsundergoingtransjugularintrahepaticportosystemicshunttipsimplantation
AT federicocollettini sarcopeniaasariskfactorinpatientsundergoingtransjugularintrahepaticportosystemicshunttipsimplantation
AT dirkschnapauff sarcopeniaasariskfactorinpatientsundergoingtransjugularintrahepaticportosystemicshunttipsimplantation
AT maximiliandebucourt sarcopeniaasariskfactorinpatientsundergoingtransjugularintrahepaticportosystemicshunttipsimplantation
AT bernhardgebauer sarcopeniaasariskfactorinpatientsundergoingtransjugularintrahepaticportosystemicshunttipsimplantation
AT dominikgeisel sarcopeniaasariskfactorinpatientsundergoingtransjugularintrahepaticportosystemicshunttipsimplantation
AT georgboning sarcopeniaasariskfactorinpatientsundergoingtransjugularintrahepaticportosystemicshunttipsimplantation